Cyclophosphamide
- Product NDC
- 70860-218
- 11-digit product format
- 708600218
- Labeler code
- 70860
- Product ID
- 70860-218_7eaabaf5-ac12-406b-8432-8e01db8e519d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- cyclophosphamide
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Athenex Pharmaceutical Division, LLC.
- Application
- NDA212501
- Marketing category
- NDA
- Marketing start
- 2020-12-11
- Marketing end
- 0000-00-00
- Substance
- CYCLOPHOSPHAMIDE ANHYDROUS
- Active strength
- 200 mg/mL
- Pharmacologic classes
- Alkylating Activity [MoA],Alkylating Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70860-218-03 | 70860021803 | 1 VIAL in 1 CARTON (70860-218-03) > 2.5 mL in 1 VIAL | 1 vial | 2020-12-11 | 0000-00-00 | No | No | Current |
| 70860-218-05 | 70860021805 | 1 VIAL in 1 CARTON (70860-218-05) > 5 mL in 1 VIAL | 1 vial | 2020-12-11 | 0000-00-00 | No | No | Current |
| 70860-218-10 | 70860021810 | 1 VIAL in 1 CARTON (70860-218-10) > 10 mL in 1 VIAL | 1 vial | 2021-11-21 | 0000-00-00 | No | No | Current |